Epidemiology Midterm 2

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/57

encourage image

There's no tags or description

Looks like no tags are added yet.

58 Terms

1
New cards

Necessary (causal relationship)

disease will not happen without this factor

2
New cards

Sufficient

with this factor, the disease will exist

3
New cards

Characteristics of a cause

time order (cause then outcome), association (correlation between cause and outcome), direction (change in cause —> change in outcome)

4
New cards

Counterfactual

difference in effect with and without cause

5
New cards

Randomized Control Trial

accounts for inherent missing data of potential outcomes, only possible differences come from intervention, differences after randomization, or random chance

6
New cards

strong RCT

excludability (can exclude other factors), non-interference (treatment of one unit doesn’t affect other units)

7
New cards

How to randomly assign groups

participants assigned to treatment/control groups randomly

8
New cards

stratified randomization

stratify by potentially confounding characteristics

9
New cards

cluster randomization

randomize hospitals/schools/etc.

10
New cards

crossover design

patients switch between treatments/others - need to have effect be temporary

11
New cards

non-inferiority/equivalence designs

test if one treatment is the same or better than an existing one

12
New cards

issues with RCT

non-adherence to treatment, unethical (?), impossible, against policy

13
New cards

to assert an association

accurately measure outcome and exposure, see if outcome is different w/ or w/out exposure

14
New cards

cohort study participants classified based on

exposure

15
New cards

cohort studies look at associations with

incident disease

16
New cards

case-control study participants classified based on

outcome

17
New cards

case-control studies look at associations with

prevalent disease

18
New cards

options in selecting population for cohort studies

select on basis of exposure, or select defined population

19
New cards

prospective cohort studies

select population, sort into who has exposure/follow to see who gets exposure, follow over time to see who develops outcome

20
New cards

prospective pros/cons

pros: know exposure predates outcome

cons: expensive, long time to findings

21
New cards

retrospective cohort studies

identify population with past exposure, identify who has disease

22
New cards

retrospective pros/cons

pros: faster and cheaper

cons: aren’t collecting data yourself, data may not exist, difficult follow-up

23
New cards

relative risk

proportion who develop disease among exposed / proportion who develop disease among unexposed

24
New cards

incidence rate ratio

#of cases of disease per person-year of exposed / #of cases of disease per person-year of unexposed

*used if participants are in study for varying amounts of time

25
New cards

hypothesis testing

null: there is no difference in groups

alternative: there is a difference

(assuming we accounted for other reasons for difference)

26
New cards

statistical vs. clinical difference

with large sample size, small associations can be statistically significant, but not significant enough to address clinically/practically

27
New cards

case-control study design

identify people with and without disease, determine past exposure

28
New cards

case-control, prevalence or incidence cases?

prevalence: easier to find, more bias because factors/exposures could be because of development of disease

29
New cards

choosing control population

should be from same population as cases, and matching on confounders

30
New cards

sources of controls

hospitals, dead controls, friends/neighbors, random population

31
New cards

group matching

match on general characteristics: ex. 25% male cases —> 25% male controls

requires cases to be found before controls

32
New cards

individual matching

one case has x, y, z characteristics —> one control has x, y, z characteristics

33
New cards

challenges with matching

eliminates ability to investigate effect of the matching characteristics (since it is balanced), cases must be found before controls, hard to find individual matches, may accidentally match (if matching race, then accidentally match on geography)

34
New cards

strengths of matching

easy to do, only matching can really manage some factors that are strongly associated

35
New cards

weaknesses of matching

can be impossible, limits how representative of the population the study is, can’t be undone if you accidentally match on variables of interest

36
New cards

case-control pros/cons

pros: cheap, fast, multiple potential exposures, better for rare diseases - don’t have to wait for them to develop

cons: can’t always determine time-order, exposure associated with survival and not incidence, inaccurate recall, comparison groups harder to define

37
New cards

odds

probability of something happening/probability of something not happening

38
New cards

odds ratio

odds of exposure among cases/odds of exposure among controls

(a/c)/(b/d)

39
New cards

odds ratio interpretation

greater than 1: exposure associated with more disease

40
New cards

odds ratio can be estimate of relative risk/prevalence if:

cases representative of all people with disease in the population with regard to exposure history, and disease being studied doesn’t occur frequently among people unexposed

41
New cards

odds ratio with matched pairs

b/c

42
New cards

cross-sectional study design

identify population, identify exposure and disease status

*use relative prevalence

43
New cards

cross-sectional pros/cons

pros: population-representative, repeated shows changes in population

cons: survivor bias, impossible to know time-order

44
New cards

population attributable risk

(incidence in pop - incidence in nonexposed) / (incidence in pop)

45
New cards

attributable risk among exposed

(incidence in exposed - incidence in nonexposed) / (incidence in nonexposed)

46
New cards

guidelines for causality

temporal relationship, strength of association, dose-response relationship, replication of findings, biological/sociological plausibility, consideration of alternate explanations, cessation of exposure, consistency with other knowledge, specificity of the association

47
New cards

dose-response relationship

increase in disease as increase in exposure can support causal relationship

48
New cards

cessation of exposure

if exposure stops, disease stops (not necessary for causal, but can support - like inverse dose-response relationship)

49
New cards

specificity of associations

dumb, one exposure causes one outcome (and one outcome associated with one exposure)

50
New cards

confounding variable

causes outcome of interest, associated with exposure of interest, not in direct causal pathway

real association, but not causal

51
New cards

address confounding

study design (matching, randomization), analysis (stratification, adjustment - like weighted average)

52
New cards

selection bias

systematic error in selection of participants, selections predispose an association

53
New cards

nonresponse bias

groups with particular illness/exposure more likely to participate

54
New cards

information bias

means of collecting information is inadequate

55
New cards

types of information bias

recall, rumination, reporting, wish, interviewer

56
New cards

observer bias

lean one way with ambiguous cases

57
New cards

respondent bias

participant errs in if they have the disease

58
New cards

types of combined selection/information bias

detection (groups more likely to be detected), survival (actually associated with survival not cause), temporal (factor results from disease, doesn’t cause it), lead-time (screened earlier affects survival time)